MiR-21 could control pathways such as the TGF-β1 signaling pathway by targeting SMAD7 and SPRY1 or by inhibiting PTEN, which is a known negative regulator of lung fibrosis [38]. Here, SPRY1 is linked to pulmonary fibrosis.